Source: Annual Congress 2005 - Clinical features of mycobacteriosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Park, M. Lee, Y. Kim, J. Joe, K. Kim, Y. Kim, Y. Choi (Busan, Republic Of Korea). Factors relevant to bronchostenosis after treatment of endobronchial tuberculosis. Eur Respir J 2005; 26: Suppl. 49, 4369

Member's Comments

No comment yet.

Related content which might interest you: Bronchoscopic characteristics of endobronchial tuberculosis Source: Annual Congress 2009 - Interventional pneumology Year: 2009 Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012 Pulmonary tuberculosis in elderly patients – particular endobronchial aspects Source: Annual Congress 2008 - Difficult tuberculosis cases Year: 2008 Frequency of endobronchial tuberculosis in patients with active pulmonary tuberculosis is high Source: Eur Respir J 2004; 24: Suppl. 48, 33s Year: 2004 Clinical and bronchoscopic features in endobronchial tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 23s Year: 2006 Aspects of diagnosis and treatment in pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 168s Year: 2002 Factors effecting the development of radiological sequelae of pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 32s Year: 2004 Surgical treatment of pulmonary tuberculosis Source: Eur Respir Monogr 2013; 61: 20-36 Year: 2013 Clinical characteristics and outcomes of surgically resected solitary pulmonary nodules due to nontuberculous mycobacterial infections Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004 The clinical significances of bronchial anthracofibrosis in the patients with endobronchial tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 202s Year: 2004 Exposure to mycobacterium tuberculosis during bronchoscopy in patients with unexpected pulmonary tuberculosis Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Miliary tuberculosis: Diagnosis difficulties and prognosis factors Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Factors associated with delay in treatment initiation for pulmonary tuberculosis Source: ERJ Open Res, 6 (1) 00161-2019; 10.1183/23120541.00161-2019 Year: 2020 Endobronchial valve treatment for cavitary pulmonary diseases caused by non-tuberculosis mycobacteria. Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Surgical treatment of first-found destructive pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions Year: 2012 Endobronchial tuberculosis: clinical and bronchoscopic features Source: Eur Respir J 2006; 28: Suppl. 50, 27s Year: 2006 Incidence of mycobacterium tuberculosis in patients with bronchial anthracofibrosis Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis Source: Eur Respir Rev 2009; 18: 299-301 Year: 2009 Bronchoscopic finding of anthracofibrosis is associated with active tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 308s Year: 2001